Business · 20/03/2006Updated: 10/17/2026 · 1 min read
FDA, NCI, and CMS Sign Memorandum of Understanding to Improve Cancer Therapies
Summary
The US FDA, National Cancer Institute, and Centers for Medicare and Medicaid Services have agreed to collaborate on a strategic plan to enhance the use of biomarkers in cancer treatment, aiming to develop safer and more effective therapies.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →